According to their study, individuals with MetS show systemic elevations in both oxidative stress, which can be verified in terms of thiobarbituric acid reactive substances (TBARS) levels, and inflammatory markers, such as osteopontin, CRP, and SAA. This evidence concerns the gene SPP1 and metabolic syndrome.